Today's Readout newsletter: Sky high deal expectations going into JPM 2024, no p...
Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generat...
Hospitals try on a new pitch to investors: other ways of making money, besides p...
In honor of JPM Week, you're reading a special edition of our biotech newsletter...
UnitedHealth Group is looking to buy The Corvallis Clinic. It already employs or...
A drug pricing expert asks, "If importation doesn’t work – and it’s going to be ...
Medicare Advantage members continue to go to the doctor and get health care proc...
Several U.S. lawmakers are investigating the prices charged by four large drug c...
“We are not cash rich right now. We're not in a position where we can do large a...
Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another str...
Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months...
Boston Scientific said it will buy Axonics, a device company tackling urinary an...
Lilly's plan to offer its Zepbound weight-loss drug directly may make it easier ...
Johnson & Johnson said Monday it would purchase Ambrx Biopharma for nearly $2 bi...
Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of ...
The VC firm has hired Jeff Jonas, Sage’s former chief executive, and Al Robichau...
